The use of fibrin sealant in CABG surgery. A pilot study.

• Conditions: bloedingen; coronary artherosclerosis; stenosis of cardiac arteries; 10011082

• Registration Number: NL-OMON30606
• Lead Sponsor: Stichting Sanquin bloedvoorziening

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 13 May 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 40

Inclusion Criteria

CABG patients with a minimum age of 18 years
Revisions of CABG

Exclusion Criteria

Patients with congenital or acquired coagulation deseases
Patients with thrombopenia, < 100 x 10*9 PLT/L

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Numbers of bleedingstops/complete hemostasis, at least 5 minutes after<br /><br>restoration of the blood flow.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Number of anastomoses<br /><br>Number of bleedings stopped<br /><br>Nummer of bloedtransfusies<br /><br>Amounts of ml fibrin sealant applied</p><br>